NGM BIOPHARMACEUTICALS INC Business Operations Contracts & Agreements
8 Contracts & Agreements
- Collaboration Agreements (2 contracts)
- Indemnification Agreements (1)
- Sales Agreements (5)
- Amendment No. 7 on December 22, 2020 to Multi-Product Licence Agreement by and between NGM Biopharmaceuticals, Inc. and Lonza Sales AG, dated as of October 31, 2014 (Filed With SEC on March 15, 2021)
- Amendment No. 8 on February 10, 2021 to Multi-Product Licence Agreement by and between NGM Biopharmaceuticals, Inc. and Lonza Sales AG, dated as of October 31, 2014 (Filed With SEC on March 15, 2021)
- Multi-Product Licence Agreement by and between NGM Biopharmaceuticals, Inc. and Lonza Sales AG, dated as of October 31, 2014, as amended by Amendment No. 1 on July 28, 2015,... (Filed With SEC on April 1, 2019)
- Multi-Product Licence Agreement by and between NGM Biopharmaceuticals, Inc. and Lonza Sales AG, dated as of October 31, 2014, as amended by Amendment No. 1 on July 28, 2015,... (Filed With SEC on March 25, 2019)
- Multi-Product Licence Agreement by and between NGM Biopharmaceuticals, Inc. and Lonza Sales AG, dated as of October 31, 2014, as amended by Amendment No. 1 on July 28, 2015,... (Filed With SEC on September 28, 2018)
- First Amendment to Research Collaboration, Product Development and License Agreement by and between NGM Biopharmaceuticals, Inc. and Merck Sharp & Dohme Corp., dated as of January... (Filed With SEC on September 28, 2018)
- Research Collaboration, Product Development and License Agreement by and between NGM Biopharmaceuticals, Inc. and Merck Sharp & Dohme Corp., dated as of February 18, 2015 (Filed With SEC on September 28, 2018)
- Form of Indemnification Agreement, by and between NGM Biopharmaceuticals, Inc. and each of its directors and executive officers (Filed With SEC on September 28, 2018)
